SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amylin Pharmaceuticals, Inc. Release: New Clinical Data Analyses Show Metreleptin Reduced Blood Glucose and Triglyceride Levels in Patients With Rare Forms of Lipodystrophy